International Agency for Research on Cancer (IARC ) International Agency for Research on Cancer (IARC) , Fr. Center International de Recherche sur le Cancer (CIRC) ) is an international research organization, part of the World Health Organization , one of the specialized agencies of the United Nations . The agency's headquarters is located in Lyon , France .
| International Agency for Research on Cancer | |
|---|---|
| Membership | 22 states |
| Headquarters |  Lyon , France , 150 Cours Albert Thomas |
| official languages | English , French |
| Executives | |
| Head of IARC (general director) | Christopher Wilde |
| Base | |
| Base | 1965 |
| Parent organization | |
| iarc.fr | |
IARC is responsible for coordinating and conducting research on the causes of cancer in humans and carcinogenesis mechanisms, as well as developing scientific strategies for combating cancer. It participates in epidemiological and laboratory research and the dissemination of scientific information through publications, meetings, training courses and fellowships.
The main goal of the International Agency for Research on Cancer is to promote international cooperation in the field of cancer research. For this, the organization provides the planning and control of scientific research in the field of oncology related to the etiology of cancer, treatment and prevention of cancer. The tasks of the International Agency for Research on Cancer also include education and training for oncology, the implementation of research and development projects by the agency’s staff. The scientific program of the organization is determined by the scientific council. The Agency regularly publishes a series of monographs on topical oncology issues and the results of studies.
Content
History
The International Agency for Research on Cancer (IARC) was created in May 1965 at the 18th session of the World Health Assembly under the auspices of the World Health Organization and in the development of the initiative of French President Charles de Gaulle , who proposed to allocate up to 0.5% of the costs of developed countries for the fight against cancer for military purposes. Five countries became the founders of the organization: Germany , France , Italy , Great Britain and the USA .
Currently, IARC is a member of 22 states - the six founding countries, as well as: Australia , Austria , Belgium , Denmark , Canada , India , Ireland , Spain , Norway , the Netherlands , Republic of Korea , Russian Federation , Finland , Sweden , Switzerland , Japan and Turkey [2] .
Structure
Currently, the International Agency for Research on Cancer has six departments:
- epidemiology and biological statistics
- Department of Environmental Oncogenics
- biological oncogenesis
- chemical oncogenesis
- training department
- Department for the Coordination of Interdisciplinary Research Programs
Classification of carcinogenic factors
IARC experts have developed a classification of factors of various nature (chemical, physical, biological) into carcinogenic activity in relation to humans.
IARC categorized substances, mixtures, and exposure factors into five categories:
- Category 1 : carcinogenic to humans.
- Category 2A : highly likely to be carcinogenic to humans.
- Category 2B : Probably carcinogenic to humans.
- Category 3 : not classified as carcinogenic to humans.
- Category 4: not carcinogenic to humans.
- Group 1 includes compounds, groups of compounds, production processes or occupational exposure, as well as natural factors for which reliable information on carcinogenicity for humans exists. In exceptional cases, this group includes factors for which there is insufficient evidence in favor of carcinogenicity for humans, however, there is convincing evidence of carcinogenicity for animals, and carcinogenicity is provided by known mechanisms [3] .
- Group 2 combines factors that are probably carcinogenic to humans.
- Subgroup 2A includes factors for which there is limited evidence (or insufficient evidence) in favor of carcinogenicity in humans, and sufficient evidence in favor of carcinogenicity in animals [3] .
- Subgroup 2B includes factors for which there is limited evidence (or insufficient evidence) in favor of carcinogenicity in humans, and almost sufficient evidence in favor of carcinogenicity in animals. [3]
- Subgroup 2A includes factors for which there is limited evidence (or insufficient evidence) in favor of carcinogenicity in humans, and sufficient evidence in favor of carcinogenicity in animals [3] .
- Group 3 includes factors for which there is insufficient evidence in favor of carcinogenicity in humans and there is limited evidence in favor of carcinogenicity in animals [3] .
- Group 4 includes factors for which there is convincing evidence of a lack of carcinogenicity for humans (IARC experts have so far attributed only the substance to caprolactam ) [3] [4] .
IARC and Russia
In 1992 , Russia was stripped of its voting rights at sessions of the Governing Council of the International Agency for Research on Cancer due to arrears of membership fees to the budget of this organization.
In 2006 , the Government of the Russian Federation ordered the reinstatement of the Russian Federation’s membership in IARC since 2007 , with annual membership dues and debt repayments of more than $ 9 million over 10 years.
In April 2007 , Lyon, Minister of Health of the Russian Federation Mikhail Zurabov and IARC Director Peter Boyle signed an agreement on the restoration of cooperation. Russia paid its contribution in the amount of 997.7 thousand dollars and received in the form of grants from the EU and IARC 1.3 million dollars for two joint projects launched in 2003 under the program “Prevention of socially significant noncommunicable diseases, improving health and reducing mortality Of Russia. " In connection with the signing of the agreement, Mikhail Zurabov admitted that a number of problems in Russian health care are associated with the weakening of international contacts in the scientific field and said that it was time to "return to active cooperation." [5] [6]
See also
- International Union Against Cancer (IUCC)
- European Organization for Research and Treatment of Cancer (EORTC)
- National Cancer Institute (USA)
- Crayfish
- Oncology
- Carcinogens
- Mutagens
- Toxicology
- Air pollution
Notes
- ↑ About the International Agency for Research on Cancer - World Health Organization .
- ↑ Membership
- ↑ 1 2 3 4 5 Preamble // IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. - IARC, 2006.
- ↑ Carcinogenic factors and cancer risk
- ↑ Russia has returned to the International Agency for Research on Cancer. RIA Novosti 05/10/2007
- ↑ The Russian Federation has resumed cooperation with the International Agency for Research on Cancer. All-Russian Medical Portal